Caris Life Sciences, Inc.
CAI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $24 | -$72 | -$103 | -$66 |
| Dep. & Amort. | $7 | $6 | $7 | $12 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $14 | $28 | $15 | $4 |
| Change in WC | $13 | -$1 | $13 | -$4 |
| Other Non-Cash | $4 | $46 | $36 | -$9 |
| Operating Cash Flow | $62 | $7 | -$31 | -$63 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | -$1 | -$3 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$7 | -$1 | -$3 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $24 | -$0 | -$0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$17 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | $129 | $1 | -$0 |
| Financing Cash Flow | -$21 | $681 | $1 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $34 | $687 | -$33 | -$66 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $723 | $35 | $68 | $246 |
| End Cash | $757 | $723 | $35 | $180 |
| Free Cash Flow | $55 | $6 | -$34 | -$66 |